NextGen Healthcare Inc

NextGen Healthcare, Inc. provides software and services that empower ambulatory healthcare practices to manage the risk and complexity of delivering care in the rapidly evolving U.S. healthcare system. Its portfolio includes tightly integrated solutions that deliver on ambulatory healthcare imperatives including population health, care management, patient outreach, telemedicine, and nationwide clinical information exchange. The company was founded by Sheldon Razin in 1974 and is headquartered in Irvine, CA.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q4 2024

NextGen reports strong Q1 performance, focuses on strategic growth

NXGN's Q1 2023 earnings call showcased strong performance, strategic investments, and a focus on future growth. Despite challenges related to a security incident and guidance factors, the company remains optimistic and focused on accelerating growth in fiscal '24 and '25.

NXGN reports strong Q1 2024 results, transitions to subscription model

NXGN delivered strong financial performance, with a focus on transitioning to a subscription-based model and investing in innovation. While facing margin challenges and a DOJ settlement impact on free cash flow, the company is well-positioned for growth in attractive markets like behavioral health and integrated care.

NextGen Healthcare reports resilient Q3 performance and strategic acquisitions

NextGen Healthcare delivered strong Q3 results despite a cyber-attack, with double-digit revenue growth and operational improvements.
The TSI Healthcare acquisition is expected to enhance revenue and earnings, expanding NextGen's market reach.
Challenges include margin pressure and ongoing costs related to the TSI acquisition, requiring careful management.
Opportunities lie in talent acquisition, technology investments, and strategic growth initiatives for long-term success.

NextGen Healthcare reports strong Q4 earnings and eyes strategic investments

NextGen Healthcare's Q4 showed solid performance and record bookings growth. The company is focused on commercial execution, innovation investments, and sustained organic growth initiatives for FY 24. With a positive outlook for FY 24, the company aims to capitalize on M&A opportunities and strategic investments.

NextGen Healthcare Inc reports solid Q1 results and eyes growth

NextGen Healthcare Inc's Q1 2024 performance reflects growth, stability, and a strategic focus on innovation and client expansion.
While facing short-term revenue challenges and cash flow issues, the company's strengths in client acquisition and financial discipline position it well for the future.
Opportunities in new markets and care quality improvement initiatives provide avenues for sustained growth and profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NextGen Healthcare offers a range of software, services, and analytics solutions to medical and dental group practices. The company's portfolio delivers foundational capabilities to empower physician success, enrich the patient care experience, and enable the transition to value-based healthcare. The company was founded in 1974 and is headquartered in Irvine, California.

IRVINE, Calif.--(BUSINESS WIRE)--Sheldon Razin, who collectively with Lance Rosenzweig and the other participants in his solicitation owns approximately 15.2% of the outstanding common shares of NextGen Healthcare, Inc. (NASDAQ: NXGN) (“NextGen Healthcare” or the “Company”), today filed a revised preliminary proxy statement with the U.S. Securities and Exchange Commission in connection with the Company's Annual Meeting of Shareholders (the “Annual Meeting”) scheduled for October 13, 2021. The r

The Razin Group Files Revised Preliminary Proxy Statement in Connection with NextGen Healthcare's 2021 Annual Meeting

NextGen's (NXXGN) solutions collaborate with Neighborhood Health to provide care to Nashville's homeless community through the latter's street medicine program.

NextGen's (NXGN) Solutions to Boost Care for Homeless Community

ATLANTA--(BUSINESS WIRE)---- $NXGN #NextGenHealthcare--NextGen Healthcare recognized for third straight year as Market Leader in Medical Practice Management in FeaturedCustomers report.

NextGen Healthcare Recognized for Third Straight Year as Market Leader in Medical Practice Management

ATLANTA--(BUSINESS WIRE)---- $NXGN #AmbulatoryHealthcare--NextGen Healthcare Recognized by Healthcare Technology Report for Its Leadership and Organizational Effectiveness

NextGen Healthcare Ranks #6 on Top 100 Healthcare Technology Companies of 2021

ATLANTA--(BUSINESS WIRE)--NextGen Healthcare releases important email that Sheldon Razin conveniently excluded in his latest release.

NextGen Healthcare Releases Important Email that Sheldon Razin Conveniently Excluded in His Latest Release

IRVINE, Calif.--(BUSINESS WIRE)--Sheldon Razin, who collectively with Lance Rosenzweig and the other participants in his solicitation owns approximately 15.2% of the outstanding common shares of NextGen Healthcare, Inc. (NASDAQ: NXGN) (“NextGen Healthcare” or the “Company”), today addressed the Company's misleading August 26th press release. The Company's disingenuous press release relies on cherry-picked excerpts from an email exchange between Mr. Rosenzweig and Nominating and Governance Commi

The Razin Group Exposes NextGen Healthcare's Alarming Attempt to Mislead Shareholders in August 26th Press Release

ATLANTA--(BUSINESS WIRE)---- $NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today issued the following statement on behalf of all members of the NextGen Healthcare Board of Directors, other than Sheldon Razin and Lance Rosenzweig: Sheldon Razin and Lance Rosenzweig are once again obstructing the Board's efforts to drive Board refreshment and reach a mutually agreeable resolution with respect to the proxy contest they have initiated. As previ

NextGen Healthcare Issues Statement

IRVINE, Calif.--(BUSINESS WIRE)--Sheldon Razin, who collectively with Lance Rosenzweig and the other participants in his solicitation owns approximately 15.2% of the outstanding common shares of NextGen Healthcare, Inc. (NASDAQ: NXGN) (“NextGen Healthcare” or the “Company”), yesterday filed a preliminary proxy statement with the U.S. Securities and Exchange Commission in connection with the Company's Annual Meeting of Shareholders (the “Annual Meeting”) scheduled for October 13, 2021. Messrs. R

Two NextGen Healthcare Directors File Preliminary Proxy Statement to Elect New Individuals to the Company's Board at the 2021 Annual Meeting

ATLANTA--(BUSINESS WIRE)---- $NXGN #AmbulatoryHealthcare--Healthcare Providers Extend Their Reach and Improve Outcomes Using NextGen Healthcare's Mobile Solution to Access EHR in the Field

NextGen® Mobile Enables Neighborhood Health to Deliver Care to Nashville's Homeless Population

ATLANTA--(BUSINESS WIRE)---- $NXGN #NextGenHealthcare--NextGen Healthcare files preliminary proxy statement in connection with Annual Meeting.

NextGen Healthcare Files Preliminary Proxy Statement in Connection with Annual Meeting

ATLANTA--(BUSINESS WIRE)---- $NXGN #NextGenHealthcare--NextGen Healthcare issues statement regarding Sheldon Razin's attempt to control the NextGen Healthcare Board of Directors.

NextGen Healthcare Issues Statement Regarding Sheldon Razin's Attempt to Control the NextGen Healthcare Board of Directors

IRVINE, Calif.--(BUSINESS WIRE)--Sheldon Razin, who collectively with the candidates he is nominating owns approximately 15.2% of the outstanding common shares of NextGen Healthcare, Inc. (Nasdaq: NXGN) (“NextGen Healthcare” or the “Company”), today announced the nomination of four additional highly-qualified and independent candidates for election to the Company's Board of Directors (the “Board”) at the upcoming Annual Meeting of Shareholders (the “Annual Meeting”) on October 13, 2021. In addi

Two NextGen Healthcare Directors Nominate Four Additional Candidates for Election to the Board at 2021 Annual Meeting

ATLANTA--(BUSINESS WIRE)---- $NXGN #NextGenHealthcare--NextGen Healthcare announces two new directors to join the board and the retirement of director James Malone from the board.

NextGen Healthcare Announces Two New Directors to Join the Board and the Retirement of Director James Malone from the Board

ATLANTA--(BUSINESS WIRE)---- $NXGN #NextGenHealthcare--NextGen Healthcare Announces Date for its 2021 Annual Meeting of Shareholders on October 13, 2021.

NextGen Healthcare Announces Date for 2021 Annual Meeting of Shareholders

ATLANTA--(BUSINESS WIRE)---- $NXGN #AmbulatoryHealthcare--Progressive NY-Based Organization Leverages NextGen Healthcare's Full Portfolio to Drive Clinical and Financial Outcomes

NextGen Healthcare Selected by Liberty Resources to Enhance Operations and Enable Whole Person Care

NextGen Healthcare, Inc. (NXGN) Q1 2022 Results - Earnings Call Transcript

ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, announced that the Ahmed D. Hussein v. Sheldon Razin, Steven Plochocki and Quality Systems, Inc. lawsuit filed in the Superior Court of the State of California for the County of Orange on October 7, 2013 concluded on July 29, 2021 with a jury verdict in favor of the Company and Messrs. Razin and Plochocki on all counts with no financial liability for the Company. As

NextGen Healthcare Fully Prevails in Hussein Trial Jury Verdict

NextGen Healthcare's (NXGN) fiscal first-quarter earnings reflect strong segmental performance.

NextGen Healthcare (NXGN) Q1 Earnings & Revenues Top Estimates

Shares of NextGen Healthcare (NASDAQ:NXGN) rose 0.1% in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 19.05% over the past year to $0.25, which beat the estimate of $0.21.

Recap: NextGen Healthcare Q1 Earnings

ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced its operating results for the fiscal first quarter ended June 30, 2021. Fiscal 2022 First Quarter Highlights Total revenue for the fiscal 2022 first quarter was $146.1 million compared to $130.9 million for the same period a year ago, or 12 percent growth. Recurring revenue accounted for 91 percent of total revenue, or $132.4 million, growing 11 perce

NextGen Healthcare Reports Fiscal 2022 First Quarter Results

ATLANTA--(BUSINESS WIRE)---- $NXGN #AmbulatoryHealthcare--Delaware Valley Community Health, Inc. (DVCH), has leveraged NextGen® Population Health to identify and prioritize people for COVID-19 vaccinations.

NextGen® Population Health Solutions Enable Delaware Valley Community Health to Identify and Treat Vulnerable Patients

Nextgen Healthcare (NXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nextgen Healthcare (NXGN) Reports Next Week: What Awaits?

NextGen Healthcare (NXGN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

Moving Average Crossover Alert: NextGen Healthcare (NXGN)

ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that it will release its fiscal 2022 first quarter ended June 30, 2021 operating results on Thursday, July 29, 2021 after market close, with a conference call to follow at 5:00 p.m. Eastern Time. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 866-342-8591 or 203-518-9713 for international call

NextGen Healthcare to Host Fiscal 2022 First Quarter Results Conference Call

NextGen's (NXGN) platform is likely to expand care to the underserved patient pool by improving the access to and delivery of whole-person care.

News for NextGen Healthcare Inc Stock (NXGN)